본문 바로가기
주메뉴 바로가기
HLBELL
ABOUT US
Greeting
What We Do
Corporate Philosophy
Main History
Organization
Location
Technology
Hutrigel® (Human Extracellular Matrix)
BleeFix® (Hemostat)
LifeLiver® (Bioartificial Liver Support System)
Intellectual Property Rights
Pipeline
Development Stage
Product
Primary Human Hepatocytes
Primary Animal Hepatocytes
PR
Notice
News
Sitemap
Contact
ENG
KOR
ENG
ABOUT US
Greeting
What We Do
Corporate Philosophy
Main History
Organization
Location
Technology
Hutrigel® (Human Extracellular Matrix)
BleeFix® (Hemostat)
LifeLiver® (Bioartificial Liver Support System)
Intellectual Property Rights
Pipeline
Development Stage
Product
Primary Human Hepatocytes
Primary Animal Hepatocytes
PR
Notice
News
SITEMAP
ABOUT US
Greeting
What We Do
Corporate Philosophy
Main History
Organization
Location
Technology
Hutrigel® (Human Extracellular Matrix)
BleeFix® (Hemostat)
LifeLiver® (Bioartificial Liver Support System)
Intellectual Property Rights
Pipeline
Development Stage
Product
Primary Human Hepatocytes
Primary Animal Hepatocytes
PR
Notice
News
PR
Biotech Company Specialized in Regenerative Medicine
News
Notice
News
News
Search
All
Title
Content
Search
라이프리버, 글로벌 바이오기업과 바이오인공간·세포치료제 개발
Date 2020-09-04
Hit 5529
라이프리버, NASH 치료제 美 효능 발표 "1.8조 시장 성큼"
Date 2020-09-04
Hit 5123
에이치엘비, 바이오그룹으로 도약 속도..라이프리버 가치↑
Date 2020-09-04
Hit 5094
Promethera Biosciences Raises EUR 10 Million in a Series C-extension Financing to Advance its Broad
Date 2020-09-04
Hit 6402
Promethera boosts Series C to €26M to join NASH race
Date 2020-09-04
Hit 4703
FIRST
PREV
1
2
3
NEXT
LAST